119 studies found for:    Open Studies | niaid
Show Display Options
Rank Status Study
1 Recruiting Interferon Responses in Eczema Herpeticum (ADEH)
Conditions: Atopic Dermatitis;   Eczema Herpeticum;   Herpes Simplex Infections;   Eczema Vaccinatum
Intervention:
2 Not yet recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
3 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
4 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
5 Recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
6 Recruiting Eosinophilic Esophagitis Databank
Conditions: Esophagitis;   Eosinophilic Esophagitis
Intervention:
7 Not yet recruiting Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
8 Recruiting Peanut Epicutaneous Immunotherapy
Conditions: Peanut Hypersensitivity;   Food Hypersensitivity;   Hypersensitivity;   Hypersensitivity, Immediate
Interventions: Biological: 250 microgram (mcg) DBV712 Viaskin Patch;   Biological: 100 microgram DBV712 Viaskin Patch;   Biological: Placebo Viaskin Patch
9 Recruiting Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
Condition: ANCA-associated Vasculitis
Intervention:
10 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
11 Recruiting Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Condition: Influenza, Human
Interventions: Biological: A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca);   Biological: A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca);   Biological: 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®);   Biological: Vaccine placebo (Leibovitz-15 [L-15]);   Biological: Vaccine placebo (FluMist®)
12 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
13 Recruiting Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine
Condition: Metapneumovirus
Interventions: Biological: 10^6 PFU rHMPV-Pa vaccine;   Biological: 10^5 PFU rHMPV-Pa vaccine;   Biological: Placebo Vaccine
14 Recruiting Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Condition: Influenza, Human
Interventions: Drug: Oseltamivir;   Drug: Oseltamivir Placebo
15 Recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
16 Not yet recruiting Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age
Condition: HIV Infections
Intervention: Drug: Rilpivirine
17 Recruiting Natural History Study of SCID Disorders
Conditions: SCID;   Leaky SCID;   Omenn Syndrome;   Reticular Dysgenesis;   ADA Deficiency;   XSCID
Intervention:
18 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
19 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
20 Recruiting Allo-antibodies in Pediatric Heart Transplantation
Condition: Pediatric Heart Transplantation
Interventions: Drug: Induction Therapy (anti-T cell antibody induction);   Drug: Tacrolimus (Prograf);   Drug: Mycophenolate Mofetil- MMF (CellCept);   Procedure: Intraoperative plasma exchange/pheresis;   Procedure: Short-term post-operative plasmapheresis;   Drug: Post-transplant course of intravenous immunoglobulin (IVIG) therapy.;   Drug: Prednisone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years